Lights and Shadows on Managing Immune Checkpoint Inhibitors in Oncology during the COVID-19 Era

SIMPLE SUMMARY: The potential interference at the immune response level between COVID-19 and cancer therapy raises key clinical questions and points out scientific issues that need to be promptly addressed. Among the therapeutic strategies available in oncological clinics, major concerns are raised...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgaletto, Chiara, Brunetti, Oronzo, Munafò, Antonio, Bernardini, Renato, Silvestris, Nicola, Cantarella, Giuseppina, Argentiero, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071446/
https://www.ncbi.nlm.nih.gov/pubmed/33921021
http://dx.doi.org/10.3390/cancers13081906

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8071446/
https://www.ncbi.nlm.nih.gov/pubmed/33921021
http://dx.doi.org/10.3390/cancers13081906

Ejemplares similares